Compare SHPH & OFAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHPH | OFAL |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 1.7M |
| IPO Year | 2022 | 2026 |
| Metric | SHPH | OFAL |
|---|---|---|
| Price | $3.91 | $0.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.6K | ★ 4.3M |
| Earning Date | 05-11-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $716,885.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 254.88 |
| 52 Week Low | $0.38 | $0.08 |
| 52 Week High | $6.15 | $3.79 |
| Indicator | SHPH | OFAL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
OFA Group provides interior design, fit-out, project management and application services in Hong Kong for commercial and residential buildings. Its interior design services include consultation, conceptualized designs, layout plans, detailed design drawings and advice on budgetary considerations, space utilization, materials, fittings, furniture, appliances and other items. Its fit-out services include the installation of protective materials, partition walls, windows, decorative fittings, furniture, fixtures, plumbing systems, switches, power outlets, telephone wiring, computer outlet covers and other electrical and wiring works. The Group is transitioning from a project-based model to a subscription-based model for AI tools, real estate development and senior care infrastructure.